ライブラリ登録: Guest
Begell Digital Portal Begellデジタルライブラリー 電子書籍 ジャーナル 参考文献と会報 リサーチ集
Critical Reviews™ in Biomedical Engineering
SJR: 0.207 SNIP: 0.376 CiteScore™: 0.79

ISSN 印刷: 0278-940X
ISSN オンライン: 1943-619X

Critical Reviews™ in Biomedical Engineering

DOI: 10.1615/CritRevBiomedEng.2017021249
pages 443-457

Thermal Therapy Approaches for Treatment of Brain Tumors in Animals and Humans

A. L. Bredlau
Departments of Pediatrics and Neurosciences, Medical University of South Carolina, Charleston, South Carolina
M. A. McCrackin
Department of Comparative Medicine, Medical University of South Carolina; Ralph H. Johnson VAMC Research Service, Charleston, South Carolina
Anjan Motamarry
Department of Pediatrics, Medical University of South Carolina, Charleston, South Carolina
Kris Helke
Ralph H. Johnson VAMC Research Service, Charleston, South Carolina
Chao Chen
Department of Cell and Molecular Pharmacology & Experimental Therapeutics, Medical University of South Carolina, Charleston, South Carolina
Ann-Marie Broome
Department of Cell and Molecular Pharmacology & Experimental Therapeutics, Medical University of South Carolina, Charleston, South Carolina
Dieter Haemmerich
Department of Pediatrics, Medical University of South Carolina, Charleston, South Carolina, USA; Department of Bioengineering, Clemson University, Clemson, South Carolina, USA

要約

Primary brain tumors are often aggressive, with short survival from time of diagnosis even with standard of care therapies such as surgery, chemotherapy, and radiation therapy. Thermal therapies have been extensively investigated as both primary and adjuvant therapy. Although thermal therapies are not yet widely used clinically, there have been several promising approaches demonstrated in both animals and humans. This review presents thermal therapy approaches in animal and human studies, including both hyperthermia (temperatures ~42°C−45°C) and thermal ablation (temperatures > 50°C). Hyperthermia is primarily used as adjuvant to chemotherapy and radiotherapy, and is the most widely studied radiation sensitizer where enhanced efficacy has been shown in human patients with brain cancer. Hyperthermia has additional beneficial effects such as immunogenic effects, and opening of the bloodbrain barrier to potentially enhance drug delivery, for example in combination with nanoparticle drug delivery systems. Thermal ablation uses high temperatures for direct local tumor destruction, and it found its way into clinical use as laser interstitial thermal therapy (LITT). This review presents various hyperthermia and ablation approaches, including a review of different devices and methods that have been used for thermal therapies, such as radiofrequency/microwaves, laser, high-intensity focused ultrasound, and magnetic nanoparticles. Current research efforts include the combination of advanced thermal therapy devices, such as focused ultrasound with radiation, as well as the use of thermal therapies to enhance chemotherapy delivery across the blood-brain barrier.


Articles with similar content:

A Review of Hyperthermia Combined With Radiotherapy/Chemotherapy on Malignant Tumors
Critical Reviews™ in Biomedical Engineering, Vol.38, 2010, issue 1
Wei Rao, Zhong-Shan Deng
Lessons Learned from Gemcitabine: Impact of Therapeutic Carrier Systems and Gemcitabine’s Drug Conjugates on Cancer Therapy
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.34, 2017, issue 1
Sathish Dyawanapelly, Animesh Kumar, Manish K. Chourasia
Photoimmunotherapy for Cancer Treatment
Journal of Environmental Pathology, Toxicology and Oncology, Vol.25, 2006, issue 1-2
Mladen Korbelik, Zheng Huang, Robert E. Nordquist, Hong Liu, Wei R. Chen
Thermal Therapy, Part 1: An Introduction to Thermal Therapy
Critical Reviews™ in Biomedical Engineering, Vol.34, 2006, issue 6
Hafid T. Alhafid, Rajeev Bansal, Riadh W. Y. Habash, Daniel Krewski
Updated Results of a Phase I Trial of Motexafin Lutetium-Mediated Interstitial Photodynamic Therapy in Patients with Locally Recurrent Prostate Cancer
Journal of Environmental Pathology, Toxicology and Oncology, Vol.25, 2006, issue 1-2
Eli Glatstein, Andreea Dimofte, Kosmas Verigos, Stephen M. Hahn, Zelig A. Tochner, Jarod Finlay, Richard Whittington, Debbie Smith, Theresa M. Busch, Rosemarie Mick, Diana C. Hsiung Stripp, S. Bruce Malkowicz, Timothy C. Zhu